Funder: Neuroendocrine Tumor Research Foundation
Due Dates (Anticipated): March 2027 (LOI) | June 2027 (Invited full application)
Funding Amounts: Up to $800,000 over four years; maximum $200,000 annually
Summary: Supports ambitious, four-year research projects with the potential to transform neuroendocrine cancer research and treatment.
Key Information: Applicants must hold an MD, PhD, MD/PhD, or equivalent and an Assistant Professor-level or higher faculty appointment.
Description
The Neuroendocrine Tumor Research Foundation (NETRF) Accelerator Awards fund groundbreaking projects with substantial aims requiring four years to complete. NETRF’s largest grant category supports ambitious research often comparable in scope to an NIH R01. Multidisciplinary collaboration is strongly encouraged, particularly teams bringing together investigators with different scientific backgrounds.
Projects must advance at least one pillar of NETRF’s Research Roadmap: early detection, new therapeutic development, or precision medicine. The foundation primarily supports transformative basic and translational research, alongside especially compelling clinical research positioned to accelerate patient benefit. The RFA includes a dedicated allocation for translational immunotherapy, emphasizing approaches with a clear path toward clinical application. NETRF also encourages research on pediatric and adolescent/young adult populations, extrapulmonary neuroendocrine carcinomas, rare primary sites, and other understudied populations.
